M&A Deal Summary |
|
|---|---|
| Date | 2010-01-27 |
| Target | Wasserburger Arzneimittelwerk |
| Sector | Life Science |
| Buyer(s) | Recipharm |
| Sellers(s) | Hospira |
| Deal Type | Divestiture |
SEARCH BY
Recipharm is a global Pharma CDMO providing a full-service offering to leading Pharmaceutical companies and Biotechs globally. Recipharm was founded in 1995 and is based in Stockholm, Sweden.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 18 |
| Sector: Life Science M&A | 5 of 12 |
| Type: Divestiture M&A Deals | 3 of 8 |
| Country: Germany M&A | 1 of 1 |
| Year: 2010 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-12-16 |
Cobra Biomanufacturing
Keele, United Kingdom Cobra Biomanufacturing plc is a provider of biologics and pharmaceuticals contract manufacturing services. Company offers stand-alone services in the areas of cell line development, GMP cell banking, stability testing, protein characterization, bioassays, analytical services. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-10-01 |
Abbott Laboratories S.A.
Madrid, Spain Abbott Laboratories, S.A. (Spain) produces solid dose, sterile ointments, oral liquids, aerosols and topical products. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 2003 |
| Sector | Life Science |
| Employees | 19,000 |
| Revenue | 4.5B USD (2014) |
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. Hospira, Inc. is based in Lake Forest, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 3 |
| Country: Germany M&A | 1 of 1 |
| Year: 2010 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-01-12 |
Hospira - Brain Functioning Monitoring Business
Lake Forest, Illinois, United States Hospira, Inc.'s Brain Functioning Monitoring Business offers neuromonitoring technologies to improve the care of patients under anesthesia or sedation. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-07-01 |
Javelin Pharmaceuticals
Cambridge, Massachusetts, United States Javelin Pharmaceuticals, Inc., headquarters in Cambridge, MA, Javelin applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs to target unmet and underserved medical needs in the pain management market. The company has one marketed drug in the U.K., an NDA-submitted drug candidate, Dyloject, and two drug candidates in U.S. advanced clinical development. |
Buy | $145M |
